4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-025897
Options or other derivatives
- Chief Commercial Officer acquired 78,188 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Garland Jonathan Todd Chief Commercial Officer | 2022-04-25 | Grant or award · Stock Option (right to buy) | +46,971 | 46,971 | D | ||
| Garland Jonathan Todd Chief Commercial Officer | 2022-04-25 | Grant or award · Restricted Stock Units | +31,217 | 31,217 | D | ||
Loading xslF345X03/doc4.xml…